Fu Yu narrows loss to $1.2m in FY2024

Revenue from continuing operations increased 10.5% year-on-year.

Fu Yu narrowed its net loss to $1.2m during the financial year 2024, improving from the $7.6m loss seen in the previous year.

The company linked this to the increased revenue and operating profits.

Revenue from continuing operations during the period increased 10.5% year-on-year to $114.9m, driven by higher sales in the medical and consumer segments.

Meanwhile, gross profit rose 27.5% to $15.5m with an improved profit margin of 13.5%.

The company’s earnings before interests, taxes, depreciation and amortisation also rose to $8.5m from $600,000 in FY 2023.

The people you want to reach are already in this room.

Every quarter, SBR lands on the desks of the founders, CFOs, and directors running Asia's most consequential companies. Every day, they open our newsletter and read our website. It's a room that took twenty years to build — and it's the one most of our partners are trying to get into.

The good news is that the door is open. We work with companies on thought leadership articles, sponsored content, industry summits across Southeast Asia, regional awards programmes, podcasts, and media placements in print and digital. The shape of the right partnership depends on what you're trying to do, which is why we'd rather start with a conversation than send a rate card.

If you have something this room should know about, tell us. We'll tell you honestly whether we can help, and how.

No rate cards until we understand the brief. It's a better use of everyone's time.

Book a meeting

| Or download the media kit (PDF)

240,000 senior readers quarterly in print Top 1,700 Singapore companies reached

7 markets across Southeast Asia